NCT06537310
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06537310
Title A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DNK | CAN | BEL | AUS

Facility Status City State Zip Country Details
Brown University Health Providence Rhode Island 02903 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
Kinghorn Cancer Centre Darlinghurst New South Wales 2010 Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
UZ Leuven Gasthuisberg Leuven 3000 Belgium Details
BC Cancer ? Vancouver Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
McGill University Health Center Montreal Quebec H4A 3J1 Canada Details
Rigshospitalet København Ø 2100 Denmark Details
Centre Leon Berard Lyon 69008 France Details
Institut Claudius Regaud Toulouse 31059 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Clinica Universidad de Navarra Pamplona Navarre 31008 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid Madrid 28027 Spain Details
Fundacion Jimenez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field